Total Iron Test · Blood

If you have ever felt unexplained fatigue, noticed your exercise tolerance slipping, or wondered whether your body is getting enough iron from your diet, this test gives you a direct answer. Serum total iron measures the actual amount of iron circulating in your bloodstream at the moment your blood is drawn, most of it riding on a transport protein called transferrin.

A standard complete blood count (CBC) can tell you whether you are anemic, but it cannot tell you why. Your hemoglobin might look fine while your iron stores are quietly draining. Or your iron might appear low on paper because your body is hiding it during an infection. Total iron, interpreted alongside ferritin and transferrin saturation (TSAT), fills in the picture that a CBC leaves blank.

What Serum Iron Actually Measures

Total iron is not a protein, hormone, or enzyme. It is elemental iron, the same mineral found in red meat and spinach, dissolved in your blood serum and bound to a carrier protein called transferrin. Your body absorbs iron through the lining of your small intestine, recycles it from old red blood cells via immune cells called macrophages, and stores the surplus in your liver. A peptide hormone called hepcidin, produced mainly by the liver, acts as the master switch: when hepcidin rises, iron absorption and release slow down; when it falls, more iron enters circulation.

Because serum iron captures only the iron in transit at one moment, it fluctuates more than almost any other routine blood test. Think of it as a snapshot of traffic on a highway rather than a count of cars in the parking lot. That is why it is almost never interpreted alone.

Heart Disease and Cardiovascular Mortality

Low serum iron is consistently linked to worse heart outcomes, especially in people who already have cardiovascular disease. In a study of about 3,200 adults with coronary artery disease followed for a median of nearly 9 years, those in the highest quarter of serum iron had roughly half the rate of cardiovascular death compared to those in the lowest quarter (about 49% lower risk), and about a third lower risk of dying from any cause. These associations held after adjusting for standard risk factors.

A separate analysis of roughly 1,900 U.S. adults with cardiovascular disease from NHANES, followed for up to 19 years, found a similar pattern: the highest quarter of serum iron was linked to about 43% lower risk of dying from any cause and roughly 74% lower cardiovascular mortality compared to the lowest quarter. The relationship with cardiovascular death was strikingly linear: the higher the iron, the lower the risk across the entire range studied.

In heart failure specifically, a study of about 2,050 patients found that each standard deviation increase in TSAT (transferrin saturation, which is calculated from serum iron) was linked to roughly 16% lower risk of death, while each standard deviation increase in serum iron was linked to about 13% lower risk. Ferritin, by contrast, showed no significant prognostic value in this population after adjustment, reinforcing that circulating iron and TSAT may be more meaningful than stored iron for predicting heart failure outcomes.

Type 2 Diabetes

Iron's relationship to diabetes runs in the opposite direction from its relationship to heart disease. In a large Catalan primary care cohort of more than 206,000 adults followed for a median of 8.4 years, those in the highest quarter of serum ferritin (a marker closely tied to total body iron) had about 51% higher risk of developing type 2 diabetes compared to the lowest quarter. Meta-analyses pooling multiple studies found that people in the top ferritin category had roughly 49% to 73% higher diabetes risk than those in the bottom category.

A Mendelian randomization study in European adults, which uses genetic variants to estimate causal effects, supported this pattern: genetically predicted higher iron status was associated with 7% to 14% lower risk of coronary artery disease but a meaningfully higher risk of type 2 diabetes.

Making Sense of the Paradox

This creates what looks like a contradiction: higher iron appears protective for your heart but harmful for your metabolism. The resolution is that iron is not a simple "more is better" or "less is better" marker. It sits in a narrow healthy window. Too little iron starves your tissues of oxygen and energy. Too much iron generates unstable oxygen molecules that damage cells, particularly in the liver and pancreas, where excess iron can impair insulin signaling. The goal is not to maximize or minimize your level but to land in the middle range where both risks are low.

Cancer Risk

In the Japan Public Health Center Study, a case-cohort analysis following roughly 4,250 adults for a median of 16.5 years, iron deficiency (ferritin below 30 ng/mL) was linked to about 23% higher total cancer risk compared to adequate iron levels. At the other extreme, iron overload was strongly linked to liver cancer, with about 4.5 times the risk. For cancers outside the liver, iron overload did not show a significant association, suggesting that the liver, as the body's main iron storage organ, bears the greatest burden when iron accumulates.

Kidney Disease

Iron status matters at both ends in kidney disease. In a cohort of about 890 patients with chronic kidney disease (CKD) followed for a median of 2.8 years, both low and high ferritin levels predicted worse kidney outcomes. Compared to the second quarter (the reference group), the lowest quarter had about 52% higher risk of doubling their creatinine or progressing to kidney failure, while the third and fourth quarters had 54% to 71% higher risk. This U-shaped pattern means that both iron depletion and iron excess appear to accelerate kidney damage.

In a pre-dialysis CKD cohort of about 1,400 patients, maintaining a TSAT above 20% was associated with lower risk of cardiovascular events and heart failure hospitalization. For people with CKD, keeping iron in a moderate range, not too low, not too high, appears to matter for both kidney and heart outcomes.

Pregnancy and Birth Outcomes

A large meta-analysis combining 44 cohort studies (over 1.8 million women) and 48 randomized trials (nearly 18,000 women) found that prenatal anemia was associated with about 29% higher risk of low birth weight and 21% higher risk of preterm birth. In the trial data, each additional 10 mg per day of supplemental iron (up to about 66 mg per day) lowered the risk of maternal anemia by about 12% and low birth weight by about 3%.

A separate systematic review of 44 studies covering nearly 128,000 mother-child pairs found mixed results: about half of the studies linked low maternal ferritin to adverse child outcomes including impaired neurodevelopment, while several studies suggested that maternal iron overload might impair growth, cognition, or increase childhood type 1 diabetes risk. Again, the pattern is a sweet spot rather than a simple "more is better" story.

Reference Ranges

Serum iron values are reported in micrograms per deciliter (µg/dL) or micromoles per liter (µmol/L) depending on the lab. Reference ranges differ by sex because men typically carry 10% to 15% higher serum iron levels than women from young adulthood through about age 70. A large cohort of roughly 55,000 adults from northern New England, measured using standardized assays, confirmed these sex-based differences and derived detailed age- and sex-specific distributions. Your own lab may report slightly different cutpoints, so always compare your results within the same lab over time.

Preventive-medicine authors have proposed an "optimal" ferritin window of roughly 20 to 100 ng/mL and TSAT of 20% to 50%, based on cardiovascular mortality data showing that ferritin above about 194 ng/mL is associated with higher all-cause mortality. For older adults, a working range of ferritin 30 to 200 ng/mL with TSAT 20% to 45% is suggested for healthy aging. These are orientation targets, not universal absolutes. A NHANES-based physiologic analysis found that signs of iron-deficient red blood cell production begin at ferritin levels around 20 µg/L in children and 25 µg/L in non-pregnant women, which is higher than many labs' lower reference limit.

When Results Can Be Misleading

Serum iron has a within-person day-to-day variation of roughly 29% to 33%, making it one of the least stable routine blood tests. In healthy young women, within-subject variation was about 29% for serum iron compared to only about 9% for total iron-binding capacity (TIBC). In anemic patients, the pattern was similar: roughly 33% for serum iron versus 11% for TIBC. A single reading that looks low or high might look completely different if you redrew blood the next morning.

• Inflammation and acute illness: Any infection, surgery, or systemic inflammation drives ferritin up (it is an inflammatory protein) and can push transferrin down, making TSAT unreliable. If your CRP (a general inflammation marker) is elevated, your iron panel should be interpreted with caution.
• Time of day: Serum iron follows a circadian rhythm, with levels typically higher in the morning and lower in the evening. Diurnal swings of 10% to 70% have been reported. Drawing blood at a consistent time of day improves comparability across readings.
• Intense exercise: A single hard workout can transiently raise or lower serum iron for hours to a full day. In rowers performing a maximal 2,000-meter effort, serum iron dropped significantly at 24 hours. After a marathon, iron and TSAT rose acutely; after an ultramarathon, they dropped. Ferritin spiked after both due to inflammation. Avoid testing within 24 to 48 hours of intense exertion.
• Obesity: Excess body fat raises hepcidin and ferritin through chronic low-grade inflammation, often making ferritin look normal or high even when usable iron is low. Adding TSAT and CRP to the panel nearly doubled detection of iron deficiency in candidates for bariatric surgery.
• Certain diabetes and heart failure medications: GLP-1 receptor agonists (like semaglutide) can lower ferritin, and SGLT2 inhibitors (like dapagliflozin or empagliflozin) can lower ferritin while raising hemoglobin by shifting iron from storage into red blood cell production. These changes do not mean you have become iron-deficient. If you are on one of these medications, check TSAT and CRP alongside ferritin for a complete picture.